Rankings
▼
Calendar
TARA FY 2024 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TARA
Protara Therapeutics, Inc.
$228M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$49M
Net Income
-$45M
EPS (Diluted)
$-2.17
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$36M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$181M
Total Liabilities
$14M
Stockholders' Equity
$167M
Cash & Equivalents
$163M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$341,000
+100.0%
Operating Income
-$49M
-$44M
-12.7%
Net Income
-$45M
-$40M
-10.3%
← Q4 2023
All Quarters
Q1 2024 →